Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$25.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis Women's Health Research: Progress, Pitfalls, and Promise Other Related Titles An Assessment of the NIH Women's Health Initiative (1993) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix L: Abbreviations and Acronyms." An Assessment of the NIH Women's Health Initiative. Washington, DC: The National Academies Press, 1993. Please select a format: Page 135   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. L Abbreviations and Acronyms CaD Calcium and vitamin D supplementation CCC Clinical Coordinating Center CHD Coronary heart disease CPS Community Prevention Study CT Clinical Trial CVD Cardiovascular disease DM Dietary modification DSMB Data Safety and Monitoring Board ERT Estrogen replacement therapy HDL-C High-density lipoprotein cholesterol HRT Hormone replacement therapy IOM Institute of Medicine LDL-C Low-density lipoprotein cholesterol NAS National Academy of Sciences NCI National Cancer Institute NIH National Institutes of Health OPR Objective Prescheduled Reassessment OS Observational Study PEPI Postmenopausal Estrogen Progestin Interventions Trial PERT Progestin-plus-estrogen replacement therapy PI Principal investigator SES Socioeconomic status WHI Women's Health Initiative Page 135 Front Matter (R1-R16) Executive Summary (1-18) Introduction (19-24) Clinical Trial (25-76) Observational Study (77-80) Community Prevention Study (81-84) Concluding Remarks (85-90) References (91-94) Appendix A: Clinical Trial Exclusion Criteria (95-100) Appendix B: U.S. House of Representatives Appropriations COmmittee (101-102) Appendix C: Statement of Task (103-104) Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health (105-108) Appendix E: Meeting Participants June, July, and August 1993 (109-112) Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial (113-114) Appendix G: Women's Health Initiative Committees (115-116) Appendix H: NIH-Sponsored Women's Health Studies (117-122) Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers (123-126) Appendix J: NIH Power Calculations (127-132) Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators (133-134) Appendix L: Abbreviations and Acronyms (135-136) Appendix M: Committee and Staff Biographies (137-142)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 135
An Assessment of the NIH Women's Health Initiative L Abbreviations and Acronyms CaD Calcium and vitamin D supplementation CCC Clinical Coordinating Center CHD Coronary heart disease CPS Community Prevention Study CT Clinical Trial CVD Cardiovascular disease DM Dietary modification DSMB Data Safety and Monitoring Board ERT Estrogen replacement therapy HDL-C High-density lipoprotein cholesterol HRT Hormone replacement therapy IOM Institute of Medicine LDL-C Low-density lipoprotein cholesterol NAS National Academy of Sciences NCI National Cancer Institute NIH National Institutes of Health OPR Objective Prescheduled Reassessment OS Observational Study PEPI Postmenopausal Estrogen Progestin Interventions Trial PERT Progestin-plus-estrogen replacement therapy PI Principal investigator SES Socioeconomic status WHI Women's Health Initiative

OCR for page 136
An Assessment of the NIH Women's Health Initiative This page in the original is blank.

Representative terms from entire chapter:

health initiative